Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Transplantation Proceedings

• Publication date

  1995-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7879050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.

  1991cited by this paper
• Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.

  1991cited by this paper
• The immunosuppressive macrolides FK-506 and rapamycin.

  1991cited by this paper
• Mixed lymphocyte reaction-induced release of soluble IL-2 receptor.

  1991cited by this paper
• Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations.

  1990cited by this paper
• Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

  1990cited by this paper
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

  1989cited by this paper
• Soluble interleukin-2 receptor level as an indicator of liver allograft rejection.

  1989cited by this paper
• Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

  1988cited by this paper
• Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

  1988cited by this paper
• Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

  1987cited by this paper
• A secreted form of the human interleukin 2 receptor encoded by an "anchor minus" cDNA.

  1986cited by this paper
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

  1975cited by this paper

• Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune®, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis 1

  2004cites this paper
• Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers

  2001cites this paper
• Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.

  2001cites this paper